Optimizing outcomes at every stage of bladder cancer: do we practice it? - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan-Feb;27(1):72-4.
doi: 10.1016/j.urolonc.2008.06.005.

Optimizing outcomes at every stage of bladder cancer: do we practice it?

Harry Herr  1 , Badrinath Konety, John Stein, Cora N Sternberg, David P Wood Jr
Affiliations
Review

Optimizing outcomes at every stage of bladder cancer: do we practice it?

Harry Herr et al. Urol Oncol. 2009 Jan-Feb.

Abstract

Defining the best practices in treating any disease can lead to optimal treatment. Establishing these best practices is difficult, and relies on clinical trials, expert opinion, and consensus decisions. Bladder cancer is a heterogeneous disease that can be either relatively benign or highly malignant depending on the grade and stage of the tumor. Determining the best practices for bladder cancer is based on the stage, grade, and presentation of the cancer. Herein we identify four clinical scenarios involving bladder cancer and discuss whether best practice guidelines are available for these clinical scenarios, and if so, how often do we follow these guidelines.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

LinkOut - more resources